Three Presentations Will Highlight the GI Windows Incision-less Anastomosis System
May 16, 2016
WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--GI Windows, Inc., a clinical-stage medical device company, today announced that the company will debut its innovative new approach to managing Type 2 diabetes at Digestive Disease Week® 2016 (DDW), taking place May 21-24 in San Diego, Calif. The company will deliver three presentations at DDW, showcasing data and video of its Incision-less Anastomosis System (IAS). Among the highlights is a presentation on the six-month results of the first-ever clinical series evaluating the endoscopic creation of a dual-path enteral diversion using the IAS.
“GI Windows is developing non-surgical procedures that treat metabolic diseases, including Type 2 diabetes in obese patients,” said Christopher C. Thompson, MD, Company Founder and Director of Developmental Endoscopy at the Brigham and Women’s Hospital (Harvard Medical School). “This novel therapy has the potential to provide an efficacious, minimally invasive option for obese patients with Type 2 diabetes and can be performed in an outpatient setting without the need for any long-term implant in the body.”
GI Windows’ IAS is designed to provide a non-surgical means to achieve small-bowel diversions similar to those performed in metabolic surgery. The GI Windows system can be placed anywhere a flexible endoscope can reach, and is deployed through the working channel of the endoscope. As it is deployed, the smart, magnetic devices self-assemble from a linear shape to an octagonal geometry. Two devices are deployed and join together through magnetic attraction to create a large-diameter, compression anastomosis. The anastomosis— a connection between two hollow or tubular structures or organs — fully forms in 7-10 days, and the magnets pass naturally through the GI tract. No foreign body is left behind.
“We are proud to be selected to present our clinical findings at DDW, the world’s premier gastroenterology meeting,” said James Wright, President and CEO of GI Windows. “The studies to be presented suggest that our Incision-less Anastomosis System holds promise as an effective alternative to pharmacology or surgery in the treatment of Type 2 diabetes, a modern-day epidemic in the United States and many parts of the world.”
The following is a schedule of GI Windows’ presentations at DDW:
Research Forum (Obesity Treatment: New Endoscopic Approaches)
Saturday, May 21, 10:45 a.m. PT, Location: 31BC (SDCC)
“A Dual-Path Enteral Bypass Procedure Created by a Novel Incisionless Anastomosis System (IAS): 6-Month Clinical Results”
Presenting Author: Evžen Machytka Author(s): Evžen Machytka, Marek Bužga, Ph.D., David B.Lautz, Marvin Ryou, Donald C. Simonson, Christopher C. Thompson
Video Session (ASGE World Cup of Endoscopy)
Tuesday, May 24, 1:59 p.m. PT, Location: 6AB (SDCC)
“Endoscopic Dual-Path Enteral Bypass Using a Magnetic Incisionless Anastomosis System (IAS)”
Presenting Author: Evžen Machytka Author(s): Evžen Machytka, Marek Bužga, Ph.D., Marvin Ryou, David B. Lautz, Christopher C. ThompsonResearch Forum (Novel Interventions for Treating Obesity and Metabolic Diseases)
Tuesday, May 24, 4:30 p.m. PT, Location: 31A (SDCC)
“Endoscopic Dual-Path Enteral Anastomosis Using Self-Assembling Magnets: First-in-Human Clinical Feasibility”
Presenting Author: Evžen Machytka Author(s): Evžen Machytka, Marek Bužga, Ph.D., Marvin Ryou, David B. Lautz, Christopher C. Thompson
About Digestive Disease Week®
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 21-24, 2016, at the San Diego Convention Center, San Diego, CA. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.
About GI Windows, Inc.
GI Windows is a clinical-stage medical device company developing an Incision-less Anastomosis System that can be used to create non-surgical procedures to treat type 2 diabetes and other metabolic diseases. The company’s technology is designed to enable durable, intestinal diversions to address these diseases, without the cost and invasiveness of surgical interventions. For more information, visit http://giwindows.com/.
Lazar Partners, LTD
Erich Sandoval, 917-497-2867 (mobile)